Indian boy's death from counterfeit antibiotics

The death of a three-year-old boy in India turns the counterfeit-antibiotics scheme from an allegation of corporate fraud into a documented human consequence. The boy died after receiving EAC’s version of amoxicillin for an infection; the drug did not work, and by the time his doctor changed the treatment, he had fallen into a coma.